Corey Goodman, who spearheaded Pfizer Inc.’s push into biotech and San Francisco’s Mission Bay, will leave the company May 31 as a result of Pfizer’s pending merger with Wyeth.
This entry was posted
on Monday, May 4th, 2009 at 4:00 am and is filed under Uncategorized.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.